TP53 and colonic neoplasm: The silencing efficiency of the vector, named pLKO‐Tet‐On‐shDKC1, was first tested in the RKO human colon cancer cells that are diploid, poorly differentiated, and express wild‐type p53, APC, and β‐catenin 29.